Eric Grinstead

Consultant at MME. Eric joined MME from Synageva BioPharma where he was SVP of Commercial Operations. Previously, Eric was VP at Alexion and has held positions with Genzyme and Amgen. He also served as President of the Safety Net Foundation and the Complement Foundation.

What Does An “Orphan Drug” Designation Mean?

In the 1990s, a visionary named Bill Aliski sparked an interest in rare diseases ...

E.M. (Mick) Kolassa, PhD
E.M. (Mick) Kolassa, PhD
author_avatar
Eric Grinstead
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call